[{"Assets_0_Q3_USD":5485788000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":574558000.0,"NetIncomeLoss_1_Q3_USD":149316000.0,"NetIncomeLoss_3_Q3_USD":287628000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":61857000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":61493000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":60476000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":60196000.0,"StockholdersEquity_0_Q3_USD":3027317000.0,"EarningsPerShareBasic_1_Q3_USD":2.47,"EarningsPerShareBasic_3_Q3_USD":4.78,"EarningsPerShareDiluted_1_Q3_USD":2.41,"EarningsPerShareDiluted_3_Q3_USD":4.68,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":469373000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1414465000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]